Back to Search Start Over

Activity of Bisnaphthalimidopropyl Derivatives against Trypanosoma brucei.

Authors :
Graça NA
Gaspar L
Costa DM
Loureiro I
Thoo-Lin PK
Ramos I
Roura M
Pruvost A
Pemberton IK
Loukil H
MacDougall J
Tavares J
Cordeiro-da-Silva A
Source :
Antimicrobial agents and chemotherapy [Antimicrob Agents Chemother] 2016 Mar 25; Vol. 60 (4), pp. 2532-6. Date of Electronic Publication: 2016 Mar 25 (Print Publication: 2016).
Publication Year :
2016

Abstract

Current treatments for African trypanosomiasis are either toxic, costly, difficult to administer, or prone to elicit resistance. This study evaluated the activity of bisnaphthalimidopropyl (BNIP) derivatives againstTrypanosoma brucei BNIPDiaminobutane (BNIPDabut), the most active of these compounds, showedin vitroinhibition in the single-unit nanomolar range, similar to the activity in the reference drug pentamidine, and presented low toxicity and adequate metabolic stability. Additionally, using a murine model of acute infection and live imaging, a significant decrease in parasite load in BNIPDabut-treated mice was observed. However, cure was not achieved. BNIPDabut constitutes a new scaffold for antitrypanosomal drugs that deserves further consideration.<br /> (Copyright © 2016, American Society for Microbiology. All Rights Reserved.)

Details

Language :
English
ISSN :
1098-6596
Volume :
60
Issue :
4
Database :
MEDLINE
Journal :
Antimicrobial agents and chemotherapy
Publication Type :
Academic Journal
Accession number :
26787703
Full Text :
https://doi.org/10.1128/AAC.02490-15